SLC43A1
Large neutral amino acids transporter small subunit 3
Also known as: LAT3_HUMAN, PB39, POV1, R00504
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75387
- Gene
- SLC43A1
- Ensembl
- ENSG00000149150
- Chromosome
- 11
- Canonical length
- 559 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Golgi apparatus,Vesicles,Plasma membrane
OverviewNCBI Gene
SLC43A1 belongs to the system L family of plasma membrane carrier proteins that transports large neutral amino acids (Babu et al., 2003 [PubMed 12930836]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
559 residues, UniProt reviewed canonical sequence.
>O75387|SLC43A1
1 MAPTLQQAYR RRWWMACTAV LENLFFSAVL LGWGSLLIIL KNEGFYSSTC PAESSTNTTQ
61 DEQRRWPGCD QQDEMLNLGF TIGSFVLSAT TLPLGILMDR FGPRPVRLVG SACFTASCTL
121 MALASRDVEA LSPLIFLALS LNGFGGICLT FTSLTLPNMF GNLRSTLMAL MIGSYASSAI
181 TFPGIKLIYD AGVAFVVIMF TWSGLACLIF LNCTLNWPIE AFPAPEEVNY TKKIKLSGLA
241 LDHKVTGDLF YTHVTTMGQR LSQKAPSLED GSDAFMSPQD VRGTSENLPE RSVPLRKSLC
301 SPTFLWSLLT MGMTQLRIIF YMAAVNKMLE YLVTGGQEHE TNEQQQKVAE TVGFYSSVFG
361 AMQLLCLLTC PLIGYIMDWR IKDCVDAPTQ GTVLGDARDG VATKSIRPRY CKIQKLTNAI
421 SAFTLTNLLL VGFGITCLIN NLHLQFVTFV LHTIVRGFFH SACGSLYAAV FPSNHFGTLT
481 GLQSLISAVF ALLQQPLFMA MVGPLKGEPF WVNLGLLLFS LLGFLLPSYL FYYRARLQQE
541 YAANGMGPLK VLSGSEVTALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC43A1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 220 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 220 nTPM
- liver: 122 nTPM
- bone marrow: 34 nTPM
- stomach: 29 nTPM
- ovary: 20 nTPM
- skin: 18 nTPM
Single-cell type
- hepatocytes: 168 nCPM
- pancreatic acinar cells: 97 nCPM
- erythrocyte progenitors: 79 nCPM
- cholangiocytes: 46 nCPM
- gastric chief cells: 44 nCPM
- distal convoluted tubule cells: 40 nCPM
Immune cell
- basophil: 11 nTPM
- gdT-cell: 11 nTPM
- T-reg: 9.5 nTPM
- MAIT T-cell: 9.2 nTPM
- myeloid DC: 8.4 nTPM
- memory CD8 T-cell: 7.7 nTPM
Brain region
- cerebral cortex: 7.3 nTPM
- white matter: 5.3 nTPM
- pons: 5.1 nTPM
- amygdala: 4.7 nTPM
- hippocampal formation: 4.4 nTPM
- thalamus: 4.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.09
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amino acid transport
- isoleucine transport
- L-leucine transport
- negative regulation of amino acid transport
- negative regulation of L-leucine import across plasma membrane
- neutral amino acid transport
- L-valine transmembrane transport
Molecular functions
- amino acid transmembrane transporter activity
- L-amino acid transmembrane transporter activity
- L-isoleucine transmembrane transporter activity
- L-leucine transmembrane transporter activity
- neutral L-amino acid transmembrane transporter activity
- L-valine transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC43A1 as an antibody target. Whether an autoantibody or antibody against SLC43A1 could matter depends on whether native SLC43A1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC43A1 is annotated at the cell surface, where native SLC43A1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC43A1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...